Nano-based vaccines are a type of vaccine that uses nanotechnology to deliver an antigen to the body in order to stimulate an immune response. The antigen is usually a protein or peptide that is derived from a virus, bacteria, or other microorganism. The nano-based vaccine is designed to be more effective than traditional vaccines, as it can deliver the antigen directly to the cells of the immune system and elicit a stronger immune response. Nanoparticles are being used to develop different types of nano-based vaccines, such as liposomal, microparticle, and polymer-based vaccines. These vaccines are designed to be more effective than traditional vaccines, as they can deliver the antigen directly to the cells of the immune system and elicit a stronger immune response. Nano-based vaccines can also be used to target specific cells and tissues, making them more efficient at delivering the antigen to the right place in the body. This is particularly beneficial for vaccines targeting immune cells, such as T-cells. Nano-based vaccines also have the potential to be developed faster than traditional vaccines, as they require less time and resources to develop. This is because the antigen is already encapsulated in the nanoparticle and therefore does not need to be isolated from the microorganism. Finally, nano-based vaccines have the potential to be produced more cost-effectively than traditional vaccines. This is because the production of nanoparticles is generally cheaper than the production of traditional vaccines.





Title : Creating materials with a desired refraction coefficient and other applications
Alexander G Ramm, Kansas State University, United States
Title : Pristine graphene coatings on metals: A disruptive approach to remarkable and durable corrosion
Raman Singh, Monash University, Australia